The clinico-ophthalmological spectrum of antiphospholipid syndrome

Ocular Immunology and Inflammation

Volumn 6, Issue 4, 1998, Pages 269-273

  Giorgi, Dario ^a,b   Gabrieli, Corrado Balacco ^a   Bonomo, Lorenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b School of Medicine ^*  (Italy)

Author keywords

Antiphospholipid syndrome; Neuro ophthalmologic features; Retinal vein artery thrombosis

Indexed keywords

ANTICOAGULANT AGENT; IMMUNOSUPPRESSIVE AGENT; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; HUMAN; IMMUNOPATHOGENESIS; OPTIC NERVE DISEASE; RETINA BLOOD VESSEL OCCLUSION; SHORT SURVEY; THROMBOSIS; TRANSITIONAL BLINDNESS; VASCULITIS;

ANIMALS; ANTIPHOSPHOLIPID SYNDROME; BLINDNESS; HUMANS; OPTIC NERVE DISEASES; RETINAL ARTERY OCCLUSION; RETINAL VEIN OCCLUSION;

EID: 0032438882     PISSN: 09273948     EISSN: None     Source Type: Journal    
DOI: 10.1076/ocii.6.4.269.4025     Document Type: Short Survey

References (21)

1. Hughes GRV. Thrombosis, abortion, cerebral disease, and lupus anticoagulant. Br Med J 1983;287:1088-1089.
2. Harris EN, Gharavi AE, Asherson RA, et al. Cerebral infarction in systemic lupus erythematosus: association with anticardiolipin antibodies. Clin Exp Rheumatol 1984;2:47-51.
3. Hughes GRV, Harris EN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986;13:486-489.
4. Derksen RHWM. Clinical manifestation and management of the antiphospholipid syndrome. Lupus 1996;5:167-169.
5. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 1990;112:682-698.
6. Farhey Y, Hess EV. Accelerated atherosclerosis and coronary disease in SLE. Lupus 1997;6:572-577.
7. George J, Shoenfeld Y. The anti-phospholipid (Hughes) syndrome: a crossroads of autoimmunity and atherosclerosis. Lupus 1997;6:559-560.
8. Levine SR, Crofts JW, Lesser GR, et al. Visual symptoms associated with the presence of a lupus anticoagulant. Ophthalmology 1988;95:686-692.
9. Acheson JF, Gregson RMC, Merry P, Schulenburg WE. Vasoocclusive retinopathy in the primary antiphospholipid antibody syndrome. Eye 1991;5:48-55.
10. Castañón C, Amigo MC, Bañales JL, et al. Ocular vaso-occlusive disease in primary antiphospholipid syndrome. Ophthalmology 1995;102:256-262.
11. Giorgi D, Vaccaro F. Vasoocclusive retinopathy: is it a classical clinical manifestation of the antiphospholipid syndrome? [letter]. Lupus 1997;6:617.
12. Asherson RA, Merry P, Acheson JF, et al. Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome. Ann Rheum Dis 1989;48:358-361.
13. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992;117:303-308.
14. Derksen RHWM, de Groot PhG, Kater L, Nieuwenhuis HK. Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis 1993;52:689-692.
15. Rivier G, Herranz MT, Khamashta MA, Hughes GRV. Thrombosis and antiphospholipid syndrome: a preliminary assessment of three antithrombotic treatments. Lupus 1994;3:85-90.
16. Khamashta MA, Cuadrado MJ, Mujic F, et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993-997.
17. Landi G, Calloni MV, Sabbadini MG, et al. Recurrent ischemic attacks in two young adults with lupus anticoagulant. Stroke 1983;14:377-379.
18. Gerber SL, Cantor LB. Progressive optic atrophy and the primary antiphospholipid antibody syndrome. Am J Ophthalmol 1990;110:443-444.
19. Jabs DA, Miller NR, Newman SA, et al. Optic neuropathy in systemic lupus erythematosus. Arch Ophthalmol 1986;104:564-568.
20. rd European Conference on SLE, Pisa, Italy, 1996. Clin Exp Rheumatol 1996;14:Suppl 16.
21. Rosenbaum JT, Simpson J, Neuwelt CM. Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide. Br J Ophthalmol 1997;81:130-132.